Aggressive management, more GP visits control BP
Results of the general practice study showed that intensive structured management of hypertension was more effective than usual care, a press briefing was told last week.
The Valsartan Intensified Primary Care Reduction of Blood Pressure (VIPER-BP) study, run by the Baker IDI Heart and Diabetes Institute, Melbourne, and sponsored by Novartis, recruited more than 2300 adults with
hypertension managed by more than 250 GPs nationally.
Patients were randomised to usual care or an intervention program including four-weekly GP visits, an integrated IT decision support tool, and titration of medication using a protocol grid or addition of agents.
Patients in the intervention group were 25% more likely to achieve the ideal blood pressure goal, lead researcher Professor Simon Stewart said.
After six months’ follow-up, 36% of patients in the VIPER-BP group achieved their target compared to 28% of usual care patients.